Acne treatment often not in line with current guidelines

Acne treatment often not in line with current guidelines

(HealthDay)—Among U.K. general practitioners, acne treatment is often not in accordance with current guidelines, according to a study published in the December issue of the Journal of the American Academy of Dermatology.

John S. Barbieri, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the duration of oral tetracycline therapy and use of topical retinoids in a . Data were collected from the Health Improvement Network database for patients with acne primarily treated by in the United Kingdom.

The researchers found that the mean therapy duration was 175.1 days. Overall, 62 percent of antibiotic courses were not associated with a topical retinoid, and 29 percent of antibiotic courses exceeded a six-month duration. Approximately 3.3 million antibiotic days per year could be avoided if all regions were to achieve uses similar to the region with the shortest mean duration of therapy.

"Prescribing behavior for oral in the treatment of acne among general practitioners is not aligned with current guideline recommendations," the authors write. "Increasing the use of topical retinoids and considering alternative agents to when appropriate represent opportunities to reduce antibiotic exposure and associated complications such as antibiotic resistance and to improve outcomes in patients treated for acne."


Explore further

Opportunity for reduced antibiotic use in acne treatment

More information: Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Acne treatment often not in line with current guidelines (2016, November 22) retrieved 15 July 2020 from https://medicalxpress.com/news/2016-11-acne-treatment-line-current-guidelines.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments